Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 9
Review
Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,454 | Dovepress* | 8,238+ | 1,292 | 9,530 | |
| PubMed Central* | 1,216 | 622 | 1,838 | ||
| Totals | 9,454 | 1,914 | 11,368 | ||
| *Since 6 December 2017 | |||||
View citations on PubMed Central and Google Scholar